Alcohol Withdrawal Syndrome

Critical Care Clinics

Volumn 28, Issue 4, 2012, Pages 549-585

  Carlson, Richard W ^a,b,c   Kumar, Nivedita N ^d   Wong Mckinstry, Edna ^e   Ayyagari, Srikala ^f   Puri, Nitin ^g   Jackson, Frank K ^a,i   Shashikumar, Shivaramaiah ^h  

^a MARICOPA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d Legacy Salmon Creek Hospital   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^h SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MIDWESTERN UNIVERSITY   (United States)

Author keywords

Alcohol withdrawal syndrome; Alcohol related disease; Alcoholism; Intensive care

Indexed keywords

ADRENALIN; BACLOFEN; BENZODIAZEPIN 2 ONE DERIVATIVE; BENZODIAZEPINE; CHLORAL HYDRATE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOMETHIAZOLE; CORTICOTROPIN RELEASING FACTOR; DEXMEDETOMIDINE; DIAZEPAM; GABAPENTIN; GLUTAMIC ACID; HOMOCYSTEINE; HYDROXYZINE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; OPIATE; PARALDEHYDE; PHENOBARBITAL; PREGABALIN; PROPOFOL; SEROTONIN; THIAMINE; TIAGABINE; TRIACYLGLYCEROL LIPASE; TRICHLOROETHANOL; UNINDEXED DRUG;

ADRENAL CORTEX INSUFFICIENCY; ADRENERGIC STIMULATION; AGITATION; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLOSTASIS; ANALGESIA; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; BRADYCARDIA; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTINUOUS INFUSION; DELIRIUM; DELIRIUM TREMENS; DESENSITIZATION; DETOXIFICATION; DIAPHORESIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG HALF LIFE; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; ENZYME ACTIVITY; EPILEPSY; GABAERGIC SYSTEM; GASTROINTESTINAL HEMORRHAGE; HALLUCINATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE PSYCHOSIS; LIVER FUNCTION; MANIA; MEDICAL HISTORY; PANCREATITIS; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PNEUMONIA; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RESPIRATION DEPRESSION; REVIEW; SCHIZOPHRENIA; SEDATION; SEIZURE; TACHYCARDIA; TREMOR; UNSPECIFIED SIDE EFFECT;

ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOL-RELATED DISORDERS; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; HYPNOTICS AND SEDATIVES;

EID: 84866516858     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2012.07.004     Document Type: Review

References (273)

1. Rehm J., Mathers C., Popova S., et al. Global burden of disease and injury and economic costs attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373(9682):2223-2233.
2. Kosten T.R., O'Connor P.G. Management of drug and alcohol withdrawal. N Engl J Med 2003, 348(18):1786-1795.
3. Saitz R. Unhealthy alcohol use. N Engl J Med 2005, 352(6):596-607.
4. 10th special report to the US Congress on alcohol and health 2000, US Dept of Health & Human Services.
5. Harwood H.J. Updating estimates of the economic costs of alcohol abuse in the United States: estimates, update methods & data 2000, Lewin Group for the National Institute on Alcohol Abuse & Alcoholism, Available at:, Accessed March 29, 2012. http://www.niaaa.nih.gov.
6. Gold M.S. Alcohol, alcohol abuse and alcohol dependence 2003, #651, CME Resource, Sacramento (CA).
7. Holt S., Stewart I.C., Dixon J.M., et al. Alcohol and the emergency service patient. Br Med J 1980, 281(6241):638-640.
8. Foy A., Kay J., Taylor A. The course of alcohol withdrawal in a general hospital. QJM 1997, 90(4):253-261.
9. Foy A., Kay J. The incidence of alcohol-related problems and the risk of alcohol withdrawal in a general hospital population. Drug Alcohol Rev 1995, 14(1):49-54.
10. Marik P., Mohedin B. Alcohol-related admissions to an inner city hospital intensive care unit. Alcohol Alcohol 1996, 31(4):393-396.
11. Baldwin W.A., Rosenfeld B.A., Breslow M.J., et al. Substance abuse related admissions to an adult intensive care unit. Chest 1993, 103(1):21-25.
12. de Wit M., Jones D.G., Sessler C.N., et al. Alcohol-use disorders in the critically ill patient. Chest 2010, 138(4):994-1003.
13. Sarff M.C., Gold J.A. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med 2010, 38S:S494-S501.
14. Moss M., Burnham E.L. Alcohol abuse in the critically ill patient. Lancet 2006, 368(9554):2231-2242.
15. Al-Sanouri I., Dikin M., Soubani A.O. Critical care aspects of alcohol abuse. South Med J 2005, 98(3):372-381.
16. Manwell L.B., Fleming M.F., Johnson K., et al. Tobacco, alcohol and drug use in a primary care sample: 90-day prevalence and associated factors. J Addict Dis 1998, 17(1):67-81.
17. Hayashida M.A., Alterman A.I., McLellan A.T., et al. Comparative effectiveness and cost of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med 1989, 320(6):358-365.
18. Soyka M., Horak M. Outpatient alcohol detoxification; implementation efficacy and outcome effectiveness of a model project. Eur Addict Res 2004, 10(4):180-187.
19. Soyka M., Schmidt S. Outpatient alcoholism treatment-24-month outcome and predictors of outcome. Subst Abuse Treat Prev Policy 2009, 4:15-23.
20. Hoffman R.S., Weinhouse G.I. Management of moderate and severe alcohol withdrawal syndromes. UpToDate 2011, UpToDate, Waltham (MA), Available at:, Accessed March 29, 2012. http://www.uptodate.com, S.J. Traub, J. Grayzel (Eds.).
21. Soderstrom C.A., Trifillis A.L., Shankar B.S., et al. Marijuana and alcohol use among 1023 trauma patients. A prospective study. Arch Surg 1988, 123(6):733-737.
22. Spies C.D., Dubisz N., Neumann T., et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of prospective randomized trial. Crit Care Med 1996, 24(3):414-422.
23. Field C.A., Classen C.A., O'Keefe G. Association of alcohol use and other high-risk behaviors among trauma patients. J Trauma 2001, 50(1):13-19.
24. Srivatsav M., Wong-McKinstry E.S., Ayagari S., et al. Review of respiratory complications in alcohol withdrawal syndrome at a public hospital. Crit Care Med 2008, 36(12):SA69.
25. Baldwin W.A., Rosenfeld B.A., Breslow M.J., et al. Substance abuse related admissions to an adult intensive care unit. Chest 1993, 103(1):21-25.
26. Mostafa S.M., Murthy B.V. Alcohol-associated admissions to an adult intensive care unit: an audit. Eur J Anaesthesiol 2002, 19(3):193-196.
27. Rootman D.B., Mustard R., Kalia V.B., et al. Increased incidence of complications in trauma patients cointoxicated with alcohol and other drugs. J Trauma 2007, 62(3):755-758.
28. Spies C.D., Nemer B., Neurmann T., et al. Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following trauma. Intensive Care Med 1996, 22(4):286-293.
29. Silver G.M., Albright J.M., Schermer C.R., et al. Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injury. J Burn Care Res 2008, 29(5):784-789.
30. Diaz L.E., Montero A., Gonzalez-Gross M., et al. Influence of alcohol consumption on immunologic status: a review. Eur J Clin Nutr 2002, 56(Suppl 3):S50-S53.
31. Fernández-Solá J., Junqué A., Estruch R., et al. High alcohol intake as a risk and prognostic factor for community acquired pneumonia. Arch Intern Med 1995, 155(15):1649-1654.
32. Ruiz M., Ewig S., Torres A., et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999, 160(3):923-929.
33. Saitz R., Ghali W.A., Moskowitz M.A. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997, 157(13):1446-1452.
34. Hudson L.D., Milberg J.A., Anardi D., et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995, 151(2 Pt 1):293-301.
35. Happel K.I., Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc 2005, 2(5):428-432.
36. Pavia C.S., La Mothe M., Kavanaugh M. Influence of alcohol on antimicrobial immunity. Biomed Pharmacother 2004, 58(2):84-89.
37. Szabo G. Consequences of alcohol consumption on host defense. Alcohol Alcohol 1999, 34(6):830-841.
38. O'Brien J.M., Lu B., Ali N.A., et al. Alcohol dependence is independently associated with sepsis, septic shock and hospital mortality among adult intensive care patients. Crit Care Med 2007, 35(2):345-350.
39. Gacouin A., Legay F., Camus C., et al. At-risk drinkers are at higher risk to acquire a bacterial infection during an intensive care unit stay than abstinent or moderate drinkers. Crit Care Med 2008, 36(6):1735-1741.
40. Guarneri J.J., Laurenzi G.A. Effect of alcohol on the mobilization of alveolar macrophages. J Lab Clin Med 1968, 72(1):40-51.
41. de Wit M., Best A.M., Gennings C., et al. Alcohol use disorders increase the risk for mechanical ventilation in medical patients. Alcohol Clin Exp Res 2007, 31(7):1224-1230.
42. McGovern P.E. Uncorking the past: the quest for wine, beer and other alcoholic beverages 2009, University of California Press, Berkeley (CA).
43. Standage T. A history of the world in six glasses 2005, Walker & Co, New York.
44. Martin D. When to say when: wine and drunkenness in ancient Rome 2010, [MA dissertation], University of Missouri, Columbia (MO).
45. Lennox W.G. Alcohol and epilepsy. Q J Stud Alcohol 1941, 11(1):1-11.
46. Adams F. The genuine works of Hippocrates 1886, William Wood & Co, New York.
47. Lennox W.G. John of Gaddesden on epilepsy. Ann Med Hist 1939, 1:283-307.
48. Smyth A. Introduction. A pleasing sinne: drink and conviviality in 17th century England 2004, xviii. Brewer DS, Cambridge (United Kingdom). A. Smyth (Ed.).
49. Earnshaw S. The pub in literature: England's altered state 2000, Manchester University Press, Manchester (United Kingdom).
50. Huss M. Alcoholismus chronicus. Eller chronisk alkoholssjukdom; ett bidrag till dyskrasiernas kännedom. Enligt egen och andras efarenhet. Stockholm (Sweden): Beckman; 1851. p. 1849-51. [in Swedish].
51. Sutton T. Tracts on delirium tremens, on peritonitis and some other internal inflammatory affections, and on the gout 1813, James Moyes for Thomas Underwood, London.
52. Ware J. Remarks on the history and treatment of delirium tremens. Med Commun Mass Med Soc 1836, 5:136-194. cited by Cutshall BJ. The Saunders-Sutton syndrome: an analysis of delirium tremens. Q J Stud Alcohol 1965;26(3):423-8.
53. Dickens C. Our mutual friend 1997, Penguin, New York. A. Poole (Ed.).
54. Griffith E. Alcohol: the world's favorite drug 2000, Thomas Dunne Books, New York, p. 73-92.
55. Peterson V., Nisenholz B., Robinson G. A nation under the influence: America's addiction to alcohol 2003, Pearson Education, Boston.
56. Djos M.G. Writing under the influence: alcoholism and the alcoholic perception from Hemingway to Berryman 2010, Palgrave-MacMillan, New York.
57. Trotter T. An essay medical, philosophical, and chemical, on drunkenness and its effects on the human body. London; 1988. (Facsimile of the 1804 London edition and based on the thesis presented to Edinburgh University in 1788). Wikipedia, The Free Encyclopedia, Wikimedia Foundation. Accessed March 29, 2012.
58. Rush B. An inquiry into the effects of ardents spirits upon the human body and mind: with an account of the means to preventing, and of the remedies for curing them 1808, Thomas Dobson, Philadelphia.
59. Osler W. The principles and practice of medicine 1895, D Appleton & Co, New York, p. 1057-71.
60. Sellers E.M., Kalant H. Alcohol intoxication and withdrawal. N Engl J Med 1976, 294(14):757-762.
61. Charney D.S., Mihic S.J., Harris R.A. Hypnotics and sedatives. Goodman & Gillman's pharmacological basis of therapeutics 2006, 402. McGraw Hill, New York, 420-1. 11th edition. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
62. A receptors in hippocampal neurons. J Pharmacol Exp Ther 1993, 264(3):1097-1103.
63. Victor M. Treatment of alcoholic intoxication and the withdrawal syndrome. Psychosom Med 1966, 28(4):636-648.
64. Thompson W.L., Johnson A.D., Maddrey W.L., et al. Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med 1975, 82(2):175-180.
65. Sainsbury M.J. The management of delirium tremens. Med J Aust 1975, 1(1):15-16.
66. Hart W.T. A comparison of promazine and paraldehyde in 175 cases of alcohol withdrawal. Am J Psychiatry 1961, 118(4):323-327.
67. Lopez-Munoz F., Ucha-Udabe R., Alamo C. The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat 2005, 1(4):329-343.
68. Gold J.A., Rimal B., Nolan A., et al. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med 2007, 35(3):724-730.
69. Hendey G.W., Dery R.A., Barnes R.L., et al. A prospective, randomized trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med 2011, 29(4):382-385.
70. Sereny G., Kalant H. Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol-withdrawal syndrome. Br Med J 1965, 1(5427):92-97.
71. Greenblatt D.J., Greenblatt M. Which drug for alcohol withdrawal?. J Clin Pharmacol 1972, 12(11):429-431.
72. Kaim S.C., Klett C.J., Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry 1969, 125(12):1640-1646.
73. Knott D.H., Beard J.D. Diagnosis and therapy of acute withdrawal from alcohol. Curr Psychiatr Ther 1970, 10:145-150.
74. Greenblatt D.J., Shader R.I. Rational use of psychotropic drugs II. Antianxiety agents. Am J Health Syst Pharm 1974, 31:1077-1080.
75. Kraus M.L., Gottlieb L.D., Horwitz R.I., et al. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985, 313(15):905-909.
76. Buchsbaum D.G., Buchanan R.G., Centor R.M., et al. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med 1991, 115(10):774-777.
77. Bush B., Shaw S., Cleary P., et al. Screening for alcohol abuse using the CAGE questionnaire. Am J Med 1987, 82(2):231-235.
78. Shaw J.M., Kolesar G.S., Sellers E.M., et al. Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1981, 1(6):382-387.
79. Sullivan J.T., Sykora M., Schneiderman J., et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989, 84(11):1353-1357.
80. Wetterling T., Kanitz R.-D., Besters B., et al. A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale). Alcohol Alcohol 1997, 32(6):753-760.
81. Ramsay M.A., Savege T.M., Simpson B.R., et al. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974, 2(5920):656-674.
82. Sessler C.N., Gosnell M.S., Grap M.J., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002, 166(10):1338-1344.
83. Simmons L.E., Riker R.R., Prato S., et al. Assessing sedation during intensive care unit mechanical ventilation with the bispectral index and the sedation-agitation scale. Crit Care Med 1999, 27(8):1499-1504.
84. Riker R.R., Picard J.T., Frasher G.L. Prospective evaluation of the sedation-agitation scale for adult critically ill patients. Crit Care Med 1999, 27(7):1325-1329.
85. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th edition (text revision).
86. Ely E.W., Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit Care Med 2001, 29(7):1370-1379.
87. Jellinek E.M. The disease concept of alcoholism 1960, Hillhouse, New Haven (CT).
88. Booth B.M., Blow F.C., Ludke R.L., et al. Utilization of acute inpatient services for alcohol detoxification. J Ment Health Adm 1996, 23(4):366-374.
89. Zacharias S., Rodriguez-Garcia A., Honz N., et al. Development of an alcohol withdrawal clinical pathway: an interdisciplinary process. J Nurs Care Qual 1998, 12(3):9-18.
90. Isabell H., Fraser H.F., Wikler A., et al. An experimental study of the etiology of "rum fits" and delirium tremens. Q J Stud Alcohol 1955, 16(1):1-33.
91. Victor M., Adams R.D. The effect of alcohol on the nervous system. Res Publ Assoc Res Nerv Ment Dis 1953, 32:526-573.
92. Carlsson C., Häggendal J. Arterial noradrenaline levels after ethanol withdrawal. Lancet 1967, 2(7521):889.
93. Perman E.S. The effect of ethyl alcohol on the secretion from the adrenal medulla in man. Acta Physiol Scand 1958, 44(3-4):241-247.
94. Krystal J.H., Staley J., Mason G., et al. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability and treatment. Arch Gen Psychiatry 2006, 63(9):957-968.
95. Ticku M.K., Burch T.P., Davis W.C. The interactions of ethanol with the benzodiazepine-GABA receptor-ionophore complex. Pharmacol Biochem Behav 1983, 18(S1):15-18.
96. Buck K.J., Hahner L., Sikela J., et al. Chronic ethanol treatment alters brain levels of gamma-aminobutyric acid a receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal seizure severity. J Neurochem 1991, 57(4):1452-1455.
97. Tsai G., Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 1998, 49(1):173-184.
98. Biermann T., Reulbach U., Lenz B., et al. N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal. J Neural Transm 2009, 116(5):615-622.
99. Haugbøl S.R., Ebert B., Ulrichsen J. Upregulation of glutamate receptor subtypes during alcohol withdrawal in rats. Alcohol Alcohol 2005, 40(2):89-95.
100. Lutz U.C. Alterations of homocysteine metabolism among alcohol dependent patients-clinical, pathobiochemical and genetic aspects. Curr Drug Abuse Rev 2008, 1(1):47-55.
101. Giacobini E., Izikowitz S., Wegman A. Urinary norepinephrine and epinephrine excretion in delirium tremens. Arch Gen Psychiatry 1960, 3:289-296.
102. Klingman G.I., Goodall M. Urinary epinephrine and levarternol excretion during acute sublethal alcohol intoxication in dogs. J Pharmacol Exp Ther 1957, 121(3):313-318.
103. Sjoquist B., Borg S., Kvande H. Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Subst Alcohol Actions Misuse 1981, 2(10):63-72.
104. Hawley R.J., Major L.F., Schulman E.A., et al. CSF levels of norepinephrine during alcohol withdrawal. Arch Neurol 1981, 38(5):289-292.
105. Hawley R.J., Major L.F., Schulman E.A. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlates with clinical signs. Arch Gen Psychiatry 1985, 42(11):1056-1062.
106. Borg S., Czarnecka A., Kvande H., et al. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcohol Clin Exp Res 1983, 7(4):411-415.
107. Sellers E.M., Zilm D.H., Degani N.C. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 1977, 38(11):2096-2108.
108. Manhem P., Nilsson L.H., Moberg A., et al. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system and clinical symptoms. Alcohol Clin Exp Res 1985, 9(3):238-243.
109. Romero C., Bugedo G., Bruhn A., et al. Experiencia preliminar del tratamiento con dexmedetomidine del estado confusional e hiperadrenergia en la unidad de cuidados intensivos. Rev Esp Anestesiol Reanim 2002, 49(8):403-406. [in Spanish].
110. Baumgartner G.R., Rowen R.C. Transdermal clonidine versus chlorodiazepoxide in alcohol withdrawal: a randomized controlled clinical trial. South Med J 1991, 84(3):312-321.
111. Baumgartner G.R., Rowen R.C. Clonidine vs chlordiazepoxide in the management of the acute alcohol withdrawal syndrome. Arch Intern Med 1987, 147(7):1223-1226.
112. Yam P.C.I., Forbes A., Kox W.J. Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anaesth 1992, 68(1):106-108.
113. Baddigam K., Russo P., Russo J., et al. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005, 20(2):118-123.
114. Rovasalo A., Tohmo H., Aantaa R., et al. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry 2006, 28(4):362-363.
115. Mayo-Smith M.F. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1997, 278(2):144-151.
116. Zilm D.H., Jacob M.S., MacLeod S.M., et al. Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcohol Clin Exp Res 1980, 4(4):400-405.
117. Worner T.M. Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am J Drug Alcohol Abuse 1994, 20(1):115-124.
118. Mayo-Smith M.F. Management of alcohol intoxication and withdrawal. Principles of addiction medicine 2009, 559-572. Lippincott Williams & Wilkins, Philadelphia. 4th edition. R.K. Ries, D.A. Fiellin, S.C. Miller (Eds.).
119. Pich E.M., Lorang M., Yeganeh M., et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995, 15(8):5439-5447.
120. Rassnick S., Heinrichs S.G., Britton K.T., et al. Microinjection of corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 1993, 605(1):25-32.
121. De Witte P., Pinto E., Ansseau M., et al. Alcohol and withdrawal: from animal research to clinical issues. Neurosci Behav Rev 2003, 27(3):189-197.
122. Bannan L.T., Potter J.F., Beevers D.G., et al. Effect of alcohol withdrawal on blood pressure, plasma rennin activity, aldosterone, cortisol and dopamine beta-hydroxylase. Clin Sci 1984, 66(6):659-663.
123. Mendelson J.H., Stein S. Serum cortisol levels in alcoholic and nonalcoholic subjects during experimentally induced ethanol intoxication. Psychosom Med 1966, 28(4):616-626.
124. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989, 243(4899):1721-1724.
125. Kumari M., Ticku M.K. Regulation of NMDA receptors by alcohol. Prog Drug Res 2000, 54:152-189.
126. Gonzales R.A., Jaworski J.N. Alcohol and glutamate. Alcohol Health Res World 1997, 2(2):120-127.
127. Davis K.M., Wu J.Y. Role of glutamatergic and GABAergic systems in alcoholism. J Biomed Sci 2001, 8(1):7-19.
128. Tsai G.E., Gastfriend D.R., Coyle J.T. The glutamatergic basis of human alcoholism. Am J Psychiatry 1995, 152(3):332-340.
129. Tsai G.E., Ragan P., Chang R., et al. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry 1998, 155(6):726-732.
130. Blevins T., Mirshahi T., Woodward J.J. Increased agonist and antagonist sensitivity of N-methyl-D-aspartate stimulated calcium flux in cultured neurons following chronic ethanol exposure. Neurosci Lett 1995, 2002(3):214-218.
131. Nagy J. Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?. Drugs 2004, 7(4):339-350.
132. Hoffman P.L., Grant K.A., Snell L.D., et al. NMDA receptors: role in ethanol withdrawal seizures. Ann N Y Acad Sci 1992, 654:52-60.
133. Grant K.A., Valverius P., Hudspith M., et al. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 1990, 176(3):289-296.
134. Krupitsky E.M., Rudenko A.A., Burakov A.M., et al. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res 2007, 31(4):604-611.
135. Krystal J.H., Petrakis I.L., Krupisky E., et al. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 2003, 1003:176-184.
136. Bleich S., Degner D., Bandelow B., et al. Plasma homocysteine is a predictor of alcohol withdrawal seizures. Neuroreport 2000, 11(12):2749-2752.
137. Bleich S., Degner D., Sperline W., et al. Homocysteine as a neurotoxin in chronic alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28(3):453-464.
138. Volkow N.D., Wang G.-J., Marynard L., et al. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res 2002, 116(3):163-172.
139. Seeman P., Tallerico T., Ko F. Alcohol-withdrawn animals have a prolonged increase in dopamine D2 high receptors, reversed by general anesthesia: relation to relapse?. Synapse 2004, 52(2):77-83.
140. Biermann T., Bonsch D., Reulbach U., et al. Dopamine and N-methyl-D-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal. J Neural Transm 2007, 114(8):1081-1084.
141. Gorwood P., Limosin F., Batel P., et al. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 2003, 53(1):85-92.
142. Schmidt L.G., Sander T. Genetics of alcohol withdrawal. Eur Psychiatry 2000, 15(2):135-139.
143. Glue P., Nutt D. Overexcitement and disinhibition: dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry 1990, 157:491-499.
144. López-Muñoz L., Alamo C., García-García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs. J Anxiety Disord 2011, 25(4):554-562.
145. Caputo F., Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des 2010, 16(19):2118-2125.
146. A receptors in the development of alcoholism. Pharmacol Biochem Behav 2008, 90(1):95-104.
147. Olsen R.W. GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 1981, 37(1):1-13.
148. Amato L., Minozzi A.L., Vecchi S., et al. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010, (3):1-111. [review], CD005063.
149. Saitz R., O'Malley S.S. Pharmacotherapies for alcohol abuse: withdrawal and treatment. Med Clin North Am 1997, 81(4):881-907.
150. Holbrook A.M., Crowther R., Lotter A., et al. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999, 160(5):649-679.
151. Legio L., Kenna G.A., Swift R.M. New developments for the pharmacological treatment of alcohol withdrawal: A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(5):1106-1117.
152. Martinotti G., de Nicola M., Frustaci A., et al. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized single-blind comparison trial. Addiction 2010, 105(2):288-299.
153. Liu J., Wang L. Baclofen for alcohol withdrawal. Cochrane Database Syst Rev 2011, (1):1-17. [review], CD008502.
154. Tabakoff B., Hoffman P.L. Neurobiology of alcohol. Textbook of substance abuse treatment 2004, American Psychiatric Publishing, Washington, DC. 3rd edition. M. Galanter, H.D. Kleber (Eds.).
155. Yu D., Zhang L., Eisele J.L., et al. Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor. Mol Pharmacol 1996, 50(4):1010-1016.
156. Zuo Y., Kuryatov A., Lindstrom J.M., et al. Alcohol modulation of neuronal nicotinic acetylcholine receptors in alpha subunit dependent. Alcohol Clin Exp Res 2002, 26(6):779-784.
157. Schucket M.A. Vulnerability factors for alcoholism. Neuropsychopharmacology: the 5th generation of progress 2002, Lippincott Williams & Wilkins, Philadelphia. K.L. Davis, D. Charney, J.T. Coyle (Eds.).
158. Barr C.S., Newman T.K., Lindell S., et al. Interaction between the serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiatry 2004, 61(11):1146-1152.
159. Elisaf M., Merkouropoulos M., Tsianos E.V., et al. Acid-base and electrolyte abnormalities in alcoholic patients. Miner Electrolyte Metab 1994, 20(5):274-281.
160. Flink E.B., Stutzman F.L., Anderson A.R., et al. Magnesium deficiency after prolonged parenteral fluid administration and after chronic alcoholism complicated by delirium tremens. J Lab Clin Med 1954, 43(2):169-183.
161. Victor M. The role of hypomagnesemia and respiratory alkalosis in the genesis of alcohol-withdrawal symptoms. Ann N Y Acad Sci 1973, 215:235-248.
162. Vinson D.C., Menezes M. Admission alcohol level: a predictor of the course of alcohol withdrawal. J Fam Pract 1991, 33(2):161-167.
163. Ferguson J.A., Suelzer C.J., Eckert G.J., et al. Risk factors for delirium tremens development. J Gen Intern Med 1996, 11(7):410-414.
164. Kraemer K.L., Mayo-Smith M.F., Calkins D.R. Independent clinical correlates of severe alcohol withdrawal. Subst Abus 2003, 24(4):197-209.
165. Feuerlein W., Reiser E. Parameters affecting the course and results of delirium tremens treatment. Acta Psychiatr Scand Suppl 1986, s329(73):120-123.
166. Wojnar M., Bizon Z., Wasilewski D. The role of somatic disorders and physical injury in the development and course of alcohol withdrawal delirium. Alcohol Clin Exp Res 1999, 23(2):209-213.
167. Schuckit M.A., Tipp J.E., Reich T., et al. The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 1995, 90(10):1335-1347.
168. Sullivan J.T. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. J Clin Psychopharmacol 1991, 11(5):291-295.
169. Turner R.C., Lichstein P.R., Peden J.G., et al. Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment. J Gen Intern Med 1989, 4(5):432-444.
170. Brown C.G. The alcohol withdrawal syndrome. Ann Emerg Med 1982, 11(5):276-280.
171. Carlson R.W., Keske B., Cortez A. Alcohol withdrawal syndrome: alleviating symptoms, preventing progression. J Crit Illn 1998, 13(5):311-317.
172. Smothers B.A., Yahr H.T. Alcohol use disorder and illicit drug use in admissions to general hospitals in the United States. Am J Addict 2005, 14(3):256-267.
173. Ballenger J.C., Post R.M. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 1978, 133:1-14.
174. Monte R., Rabunal R., Casariego E., et al. Clinical aspects: analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital. Alcohol Alcohol 2010, 45(2):151-158.
175. Booth B.M., Blow F.C. The kindling hypothesis: further evidence from a US national study of alcoholic men. Alcohol Alcohol 1993, 28(5):593-598.
176. Wright T., Myrick H., Henderson S., et al. Risk factors for delirium tremens: a retrospective chart review. Am J Addict 2006, 15(3):213-219.
177. Breese G.R., Sinha R., Heilig M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther 2011, 129(2):149-171.
178. Helzer J.E., Pryzbeck T.R. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988, 49(3):219-224.
179. Ramsay A., Vredenbrugh J., Gallagher R.M. Recognition of alcoholism among patients with psychiatric problems in a family practice clinic. J Fam Pract 1983, 17(5):829-832.
180. deRoux A., Cavalcanti M., Marcos M.A., et al. Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest 2006, 129(5):1219-1225.
181. Chang P.H., Steinberg M.B. Alcohol withdrawal. Med Clin North Am 2001, 85(5):1191-1212.
182. Behnke R.H. Recognition and management of alcohol withdrawal syndrome. Hosp Pract 1976, 11(11):79-84.
183. Hecksel K.A., Bostwick J.M., Jaeger T.M., et al. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc 2008, 83(3):274-279.
184. Carlson R.W., Raj J. Alcohol withdrawal syndrome. Saunders manual of critical care 2003, 240-243. Elsevier Science, Philadelphia. J.A. Kruse, M.P. Fink, R.W. Carlson (Eds.).
185. Carlson R.W., Cortez A., Keske B. Alcohol withdrawal syndrome: clinical problems 1999, Snow Tiger Medical Data Base, Houston (TX).
186. Ahaboucha S., Butterworth R.F. Role of endogenous benzodiazepine ligands and their GABA-A-associated receptors in hepatic encephalopathy. Metab Brain Dis 2005, 20(4):425-437.
187. Bismuth M., Funakoshi N., Cadranel J.F., et al. Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol 2011, 23(1):9-22.
188. Shane S.R., Flink E.B. Magnesium deficiency in alcohol addiction and withdrawal. Magnes Trace Elem 1991, 10(2-4):263-268.
189. Flink E.B. Magnesium deficiency in alcoholism. Alcohol Clin Exp Res 1986, 10(6):590-594.
190. Daus A.T., Freeman W.M., Wilson J., et al. Clinical experience with 781 cases of alcoholism evaluated and treated on an inpatient basis by various methods. Int J Addict 1985, 20(4):643-650.
191. Rubeiz G.J., Thill-Baharozian M., Hardie D., et al. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 1993, 21(2):203-209.
192. Yeh H.-S., Dhopesh V., Maany I. Seizures during detoxification. J Gen Intern Med 1992, 7(1):123.
193. Alldredge B.K., Lowenstein D.H., Simon R.P. Placebo-controlled trial of intravenous diphenylhydrantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 1989, 87(6):645-648.
194. Thompson W.L. Management of alcohol withdrawal syndromes. Arch Intern Med 1978, 138(2):278-283.
195. Schuckit M.A. Alcohol-related disorders. Comprehensive textbook of psychiatry 2009, Lippincott, Philadelphia. 9th edition. B.J. Sadock, V.A. Sadock, P. Ruiz (Eds.).
196. Palmstierna T. A model for predicting alcohol withdrawal delirium. Psychiatr Serv 2001, 52(6):820-823.
197. Trzepacz P.T., Baker R.W., Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988, 23(1):89-97.
198. Bergeron N., Dubois M.J., Durmont M., et al. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 2001, 27(5):859-864.
199. Maldonado J.R. Delirium in the acute care setting: characteristics, diagnosis and treatment. Crit Care Clin 2008, 24(4):657-722.
200. Meagher D.J., Trzepacz P.T. Motoric subtypes of delirium. Semin Clin Neuropsychiatry 2000, 5(2):75-85.
201. Adams Wilson J.R., Morandi A., Girard T.D., et al. The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness. Crit Care Med 2012, 40(3):835-841.
202. Girard T.D., Jackson J.C., Pandharipande P.P., et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010, 38(7):1513-1520.
203. Meagher D.J., O'Hanlon D., O'Mahony E., et al. Relationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci 2000, 12(1):51-56.
204. Pandharipande P.P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104(1):21-26.
205. Pandharipande P.P., Pun B.T., Herr D.T., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298(22):2644-2653.
206. Tune L.E., Bylsma F.W. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr 1991, 3(2):397-408.
207. Hshieh T.T., Fong T.G., Marcantonio E.R., et al. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008, 63(7):764-772.
208. Abraham E., Shoemaker W.C., McCartney S.F. Cardiorespiratory patterns in severe delirium tremens. Arch Intern Med 1985, 145(6):1057-1059.
209. Trevisan L.A., Boutros N., Petrakis I.L., et al. Complications of alcohol withdrawal: pathophysiological insights. Alcohol Health Res World 1998, 22(1):61-66.
210. Bonnet U., Specka M., Hamzavl-Abed R., et al. Severe protracted alcohol withdrawal syndrome: prevalence and pharmacological treatment at an inpatient detoxification unit-a naturalistic study. Pharmacopsychiatry 2009, 42(2):76-78.
211. Favazza A.R., Martin P. Chemotherapy of delirium tremens: a survey of physicians' preferences. Am J Psychiatry 1974, 131(9):1031-1033.
212. Moskowitz G., Chalmers T.C., Sacks H.S., et al. Deficiencies of clinical trials of alcohol withdrawal. Alcohol Clin Exp Res 1983, 7(1):42-44.
213. Amato L., Minozzi S., Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev 2011, 15(6):1-25.
214. Golberrt T.M., Sanz C.J., Rose H.D., et al. Comparative evaluation of treatments of alcohol withdrawal syndromes. JAMA 1967, 201(2):99-102.
215. Sellers E.M., Naranjo C.A., Harrison M., et al. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983, 34:822-826.
216. Weaver M.F., Hoffman H.J., Johnson R.E. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. J Addict Dis 2006, 25(2):17-24.
217. Daeppen J.B., Gache P., Landry U., et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002, 162(10):1117-1121.
218. Saitz R., Mayo-Smith M.F., Roberts M.S., et al. Individualized treatment for alcohol withdrawal. JAMA 1994, 272(7):519-523.
219. Bird R.D., Makela E.H. Alcohol withdrawal: what is the benzodiazepine of choice?. Ann Pharmacother 1994, 28(1):67-71.
220. Miller W.C., McCurdy L. A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome. Clin Ther 1984, 6(3):364-371.
221. Ritson B., Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. Drug Alcohol Depend 1986, 18(4):329-334.
222. Solomon J., Rouch L.A., Koepke H.H. Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome. Clin Ther 1983, 6(1):52-58.
223. Sellers E.M., Sandor P., Giles H.G., et al. Diazepam pharmacokinetics after intravenous administration in alcohol withdrawal. Br J Clin Pharmacol 1983, 15(1):125-127.
224. Malacrida R., Fritz M.E., Suter P.M., et al. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992, 20(8):1123-1126.
225. Riker R.R., Shehabi Y., Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients. JAMA 2009, 301(5):489-499.
226. Kollef M.H., Levy N.T., Ahrens T.S., et al. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998, 114(2):541-548.
227. Maze M., Scarfini C., Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin 2001, 17(4):881-897.
228. Spies C.D., Otter H.E., Hiske B., et al. Alcohol withdrawal severity is decreased by symptom-oriented adjusted bolus therapy in the ICU. Intensive Care Med 2003, 29(12):2230-2238.
229. Reoux J.P., Miller K. Routine hospital alcohol detoxification practice compared to symptom triggered management with an objective withdrawal scale (CIWA-Ar). Am J Addict 2009, 9(2):135-144.
230. Kahan S., Petersen K., Krimsley J. Impact of severe delirium tremens (DT) on postoperative-traumatic recovery with the application of the CIWA-Ar. Crit Care Med 2010, 38(12):793.
231. Dill C. High-dose intravenous benzodiazepine. Acad Emerg Med 2000, 7(3):308-310.
232. Hack J.B., Hoffman R.S., Nelson L.S. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?. J Med Toxicol 2006, 2(2):55-60.
233. Nolop K.P., Natow A. Unprecedented sedative requirements during delirium tremens. Crit Care Med 1985, 13(4):246-247.
234. Wolf K.M., Shaughnessy A.F., Middleton D.B. Prolonged delirium tremens requiring massive doses of medication. J Am Board Fam Pract 1993, 6(5):502-504.
235. Woo E., Greenblatt D.J. Massive benzodiazepine requirements during alcohol withdrawal. Am J Psychiatry 1979, 136(6):821-823.
236. Volicer L., Biagioni T.M. Effect of ethanol administration and withdrawal on benzodiazepine receptor binding in the rat brain. Neuropharmacology 1982, 21(7):283-286.
237. 36Cl-uptake in cerebral cortical synaptoneurosomes. J Pharmacol Exp Ther 1988, 246(1):158-164.
238. Nutt D., Adinoff B., Linnoila M. Benzodiazepines in the treatment of alcoholism. Recent Dev Alcohol 1989, 7:283-313.
239. Marik P.E. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004, 10(29):3639-3649.
240. Vasile B., Rasulo F., Candiani A., et al. The pathophysiology of the propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003, 29(9):1417-1425.
241. McCowan C., Marik P. Refractory delirium tremens: a case series. Crit Care Med 2000, 28(6):1781-1784.
242. Coomes T.R., Smith S.W. Successful use of propofol in refractory delirium tremens. Ann Emerg Med 1997, 30(6):825-828.
243. Crippen D.W. Strategies for managing delirium tremens in the ICU. J Crit Illn 1997, 12(3):140-149.
244. Darrouj J., Puri N., Prince E., et al. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008, 42(11):1703-1705.
245. Coursin D.B., Coursin D.B., Maccioli G.A. Dexmedetomidine. Curr Opin Crit Care 2001, 7(4):221-226.
246. Michaelsen I.H., Anderson J.E., Fink-Jensen A., et al. Phenobarbital versus diazepam for delirium tremens-a retrospective study. Dan Med Bull 2010, 57(8):A4169.
247. Addolorato G., Leggio L., Abenavoli L., et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 2006, 119(3):276.e13-276.e18.
248. Elsing C., Stremmel W.S., Grenda U., et al. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study. Am J Drug Alcohol Abuse 2009, 35(3):189-192.
249. Myrick H., Malcolm R., Randall P.K., et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 2009, 33(9):1582-1588.
250. Ait-Daoud N., Malcolm R.J., Johnson B.A. An overview of medications for treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav 2006, 31(9):1628-1649.
251. Longo L.P., Campbell T., Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis 2002, 21(2):55-64.
252. Malcolm R., Myrick H., Brady K.T., et al. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001, 10(Suppl):116-123.
253. Romach M.K., Sellers E.M. Management of the alcohol withdrawal syndrome. Annu Rev Med 1991, 42(1):323-340.
254. Sampliner R., Iber F.L. Diphenylhydantoin control of alcohol withdrawal seizures. JAMA 1974, 230(10):1430-1432.
255. Rathlev N.K., D'Onofrio G., Fish S.S., et al. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med 1994, 23(3):513-518.
256. Jacob M.S., Zilm D.H., MacLeod S.M., et al. Propranolol associated confused states during alcohol withdrawal. J Clin Psychopharmacol 1983, 3(3):185-187.
257. Wilkins A.J., Jenkins W.J., Steiner J.A. Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology 1983, 81(1):78-80.
258. Robinson B.J., Robinson G.M., Maling T.J., et al. Is clonidine useful in the treatment of alcohol withdrawal?. Alcohol Clin Exp Res 1989, 13(1):95-98.
259. Palestine M., Alatorre E. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide. Curr Ther Res Clin Exp 1976, 20(3):289-299.
260. Blum K., Eubanks J.D., Wallace J.E., et al. Enhancement of alcohol-withdrawal convulsions in mice by haloperidol. Clin Toxicol 1976, 9(3):427-434.
261. Krupitsky E.M., Neznanova O., Masalov D., et al. Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry 2007, 164(3):519-523.
262. Mayfield D., McLeod G., Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974, 131(10):1121-1123.
263. Hansbrough J.F., Zapata-Sirvent R.L., Carroll W.J., et al. Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients. Am J Surg 1984, 148(2):266-269.
264. Craft P.P., Foil M.B., Cunningham P.R., et al. Intravenous ethanol for alcohol detoxification in trauma patients. South Med J 1994, 87(1):47-54.
265. Rosenblaum M., McCarty T. Alcohol prescription by surgeons in the prevention and treatment of delirium tremens: historic and current practice. Gen Hosp Psychiatry 2002, 24(4):257-259.
266. Lineaweaver W.C. Massive doses of midazolam infusion for delirium tremens. Crit Care Med 1989, 17(6):597.
267. Dissanaike S., Halldorsson A., Frezza E.E., et al. An ethanol protocol to prevent alcohol withdrawal syndrome. J Am Coll Surg 2006, 203(2):186-191.
268. Weinberg J.A., Magnotti L.J., Fischer P.E., et al. Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: results of a randomized trial. J Trauma 2008, 64(1):99-104.
269. Wilkens L., Ruschulte H., Ruckoldt H., et al. Standard calculation of ethanol elimination rate is not sufficient to provide ethanol substitution therapy in the postoperative course of alcohol-dependent patients. Intensive Care Med 1998, 24(5):459-463.
270. Eggers V., Tio J., Neumann T., et al. Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med 2002, 28(10):1475-1482.
271. Hodges B., Mazur J.E. Intravenous ethanol for the treatment of alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy 2004, 24(11):1578-1585.
272. Muller C.A., Hein J. Ethanol for the treatment of alcohol withdrawal symptoms: a questionable approach. Neurologist 2010, 16(3):211.
273. Fleming M., Mihic S.J., Harris R.A. Ethanol. Goodman & Gillman's the pharmacological basis of therapeutics 2006, 591-601. McGraw Hill, New York. 11th edition. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).